Cargando…
Streptococcus pneumoniae pneumolysin and neuraminidase A convert high-density lipoproteins into pro-atherogenic particles
High-density lipoproteins (HDLs) are a group of different subpopulations of sialylated particles that have an essential role in the reverse cholesterol transport (RCT) pathway. Importantly, changes in the protein and lipid composition of HDLs may lead to the formation of particles with reduced ather...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8175417/ https://www.ncbi.nlm.nih.gov/pubmed/34124613 http://dx.doi.org/10.1016/j.isci.2021.102535 |
_version_ | 1783703053092782080 |
---|---|
author | Syed, Shahan Nissilä, Eija Ruhanen, Hanna Fudo, Satoshi Gaytán, Meztlli O. Sihvo, Sanna P. Lorey, Martina B. Metso, Jari Öörni, Katariina King, Samantha J. Oommen, Oommen P. Jauhiainen, Matti Meri, Seppo Käkelä, Reijo Haapasalo, Karita |
author_facet | Syed, Shahan Nissilä, Eija Ruhanen, Hanna Fudo, Satoshi Gaytán, Meztlli O. Sihvo, Sanna P. Lorey, Martina B. Metso, Jari Öörni, Katariina King, Samantha J. Oommen, Oommen P. Jauhiainen, Matti Meri, Seppo Käkelä, Reijo Haapasalo, Karita |
author_sort | Syed, Shahan |
collection | PubMed |
description | High-density lipoproteins (HDLs) are a group of different subpopulations of sialylated particles that have an essential role in the reverse cholesterol transport (RCT) pathway. Importantly, changes in the protein and lipid composition of HDLs may lead to the formation of particles with reduced atheroprotective properties. Here, we show that Streptococcus pneumoniae pneumolysin (PLY) and neuraminidase A (NanA) impair HDL function by causing chemical and structural modifications of HDLs. The proteomic, lipidomic, cellular, and biochemical analysis revealed that PLY and NanA induce significant changes in sialic acid, protein, and lipid compositions of HDL. The modified HDL particles have reduced cholesterol acceptor potential from activated macrophages, elevated levels of malondialdehyde adducts, and show significantly increased complement activating capacity. These results suggest that accumulation of these modified HDL particles in the arterial intima may present a trigger for complement activation, inflammatory response, and thereby promote atherogenic disease progression. |
format | Online Article Text |
id | pubmed-8175417 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-81754172021-06-11 Streptococcus pneumoniae pneumolysin and neuraminidase A convert high-density lipoproteins into pro-atherogenic particles Syed, Shahan Nissilä, Eija Ruhanen, Hanna Fudo, Satoshi Gaytán, Meztlli O. Sihvo, Sanna P. Lorey, Martina B. Metso, Jari Öörni, Katariina King, Samantha J. Oommen, Oommen P. Jauhiainen, Matti Meri, Seppo Käkelä, Reijo Haapasalo, Karita iScience Article High-density lipoproteins (HDLs) are a group of different subpopulations of sialylated particles that have an essential role in the reverse cholesterol transport (RCT) pathway. Importantly, changes in the protein and lipid composition of HDLs may lead to the formation of particles with reduced atheroprotective properties. Here, we show that Streptococcus pneumoniae pneumolysin (PLY) and neuraminidase A (NanA) impair HDL function by causing chemical and structural modifications of HDLs. The proteomic, lipidomic, cellular, and biochemical analysis revealed that PLY and NanA induce significant changes in sialic acid, protein, and lipid compositions of HDL. The modified HDL particles have reduced cholesterol acceptor potential from activated macrophages, elevated levels of malondialdehyde adducts, and show significantly increased complement activating capacity. These results suggest that accumulation of these modified HDL particles in the arterial intima may present a trigger for complement activation, inflammatory response, and thereby promote atherogenic disease progression. Elsevier 2021-05-12 /pmc/articles/PMC8175417/ /pubmed/34124613 http://dx.doi.org/10.1016/j.isci.2021.102535 Text en © 2021 The Author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Syed, Shahan Nissilä, Eija Ruhanen, Hanna Fudo, Satoshi Gaytán, Meztlli O. Sihvo, Sanna P. Lorey, Martina B. Metso, Jari Öörni, Katariina King, Samantha J. Oommen, Oommen P. Jauhiainen, Matti Meri, Seppo Käkelä, Reijo Haapasalo, Karita Streptococcus pneumoniae pneumolysin and neuraminidase A convert high-density lipoproteins into pro-atherogenic particles |
title | Streptococcus pneumoniae pneumolysin and neuraminidase A convert high-density lipoproteins into pro-atherogenic particles |
title_full | Streptococcus pneumoniae pneumolysin and neuraminidase A convert high-density lipoproteins into pro-atherogenic particles |
title_fullStr | Streptococcus pneumoniae pneumolysin and neuraminidase A convert high-density lipoproteins into pro-atherogenic particles |
title_full_unstemmed | Streptococcus pneumoniae pneumolysin and neuraminidase A convert high-density lipoproteins into pro-atherogenic particles |
title_short | Streptococcus pneumoniae pneumolysin and neuraminidase A convert high-density lipoproteins into pro-atherogenic particles |
title_sort | streptococcus pneumoniae pneumolysin and neuraminidase a convert high-density lipoproteins into pro-atherogenic particles |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8175417/ https://www.ncbi.nlm.nih.gov/pubmed/34124613 http://dx.doi.org/10.1016/j.isci.2021.102535 |
work_keys_str_mv | AT syedshahan streptococcuspneumoniaepneumolysinandneuraminidaseaconverthighdensitylipoproteinsintoproatherogenicparticles AT nissilaeija streptococcuspneumoniaepneumolysinandneuraminidaseaconverthighdensitylipoproteinsintoproatherogenicparticles AT ruhanenhanna streptococcuspneumoniaepneumolysinandneuraminidaseaconverthighdensitylipoproteinsintoproatherogenicparticles AT fudosatoshi streptococcuspneumoniaepneumolysinandneuraminidaseaconverthighdensitylipoproteinsintoproatherogenicparticles AT gaytanmeztllio streptococcuspneumoniaepneumolysinandneuraminidaseaconverthighdensitylipoproteinsintoproatherogenicparticles AT sihvosannap streptococcuspneumoniaepneumolysinandneuraminidaseaconverthighdensitylipoproteinsintoproatherogenicparticles AT loreymartinab streptococcuspneumoniaepneumolysinandneuraminidaseaconverthighdensitylipoproteinsintoproatherogenicparticles AT metsojari streptococcuspneumoniaepneumolysinandneuraminidaseaconverthighdensitylipoproteinsintoproatherogenicparticles AT oornikatariina streptococcuspneumoniaepneumolysinandneuraminidaseaconverthighdensitylipoproteinsintoproatherogenicparticles AT kingsamanthaj streptococcuspneumoniaepneumolysinandneuraminidaseaconverthighdensitylipoproteinsintoproatherogenicparticles AT oommenoommenp streptococcuspneumoniaepneumolysinandneuraminidaseaconverthighdensitylipoproteinsintoproatherogenicparticles AT jauhiainenmatti streptococcuspneumoniaepneumolysinandneuraminidaseaconverthighdensitylipoproteinsintoproatherogenicparticles AT meriseppo streptococcuspneumoniaepneumolysinandneuraminidaseaconverthighdensitylipoproteinsintoproatherogenicparticles AT kakelareijo streptococcuspneumoniaepneumolysinandneuraminidaseaconverthighdensitylipoproteinsintoproatherogenicparticles AT haapasalokarita streptococcuspneumoniaepneumolysinandneuraminidaseaconverthighdensitylipoproteinsintoproatherogenicparticles |